Search research articles
Contact Us
Filters
Showing results (1-10 of 6) with videos related to
Page
of 1
Sort By:
Biomimetics (Basel, Switzerland)
|
May 26, 2026
Adaptive Action Chunking for Robotic Imitation Learning
Qingpeng Wen, Haomin Zhu, Yuepeng Zhang, et al.
BMC Health Services Research
|
November 27, 2025
Long-term cost-effectiveness of pharmacist-managed hypertension care in China
Jingxuan Wei, Lihong Gao, Zhuying Jing, et al.
Risk Management and Healthcare Policy
|
November 20, 2025
Cost-Effectiveness of First-Line Zuberitamab-CHOP versus Rituximab-CHOP Regimens in Untreated CD20+ Diffuse Large B-Cell Lymphoma in China
Lihong Gao, Haomin Zhu, Jia Wang, et al.
International Journal of Clinical Pharmacy
|
August 19, 2025
Pharmacovigilance analysis of metabolic and nutritional adverse reactions associated with entecavir and tenofovir using the FDA adverse event reporting system database
Haomin Zhu, Baolong Ding, Zhuying Jing, et al.
Frontiers in Public Health
|
January 5, 2026
Availability, price and affordability of anticancer medicines in Jiangsu Province, China: a cross-sectional survey study
Yanping Yao, Yulu Zhu, Zhuying Jing, et al.
Therapeutic Advances in Medical Oncology
|
October 6, 2025
Cost-effectiveness analysis of belzutifan versus everolimus for previously treated advanced clear cell renal cell carcinoma in the United States and China
Baolong Ding, Hongting Yao, Tiantian Tao, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 6) with videos related to
Sort By:
Page
of 1
Biomimetics (Basel, Switzerland)
|
May 26, 2026
Adaptive Action Chunking for Robotic Imitation Learning
Qingpeng Wen, Haomin Zhu, Yuepeng Zhang, et al.
BMC Health Services Research
|
November 27, 2025
Long-term cost-effectiveness of pharmacist-managed hypertension care in China
Jingxuan Wei, Lihong Gao, Zhuying Jing, et al.
Risk Management and Healthcare Policy
|
November 20, 2025
Cost-Effectiveness of First-Line Zuberitamab-CHOP versus Rituximab-CHOP Regimens in Untreated CD20+ Diffuse Large B-Cell Lymphoma in China
Lihong Gao, Haomin Zhu, Jia Wang, et al.
International Journal of Clinical Pharmacy
|
August 19, 2025
Pharmacovigilance analysis of metabolic and nutritional adverse reactions associated with entecavir and tenofovir using the FDA adverse event reporting system database
Haomin Zhu, Baolong Ding, Zhuying Jing, et al.
Frontiers in Public Health
|
January 5, 2026
Availability, price and affordability of anticancer medicines in Jiangsu Province, China: a cross-sectional survey study
Yanping Yao, Yulu Zhu, Zhuying Jing, et al.
Therapeutic Advances in Medical Oncology
|
October 6, 2025
Cost-effectiveness analysis of belzutifan versus everolimus for previously treated advanced clear cell renal cell carcinoma in the United States and China
Baolong Ding, Hongting Yao, Tiantian Tao, et al.
Page
of 1